Very promising developments on the covid-19 treatment and vaccine fronts. First, PittCoVacc, a vaccine candidate out of the University of Pittsburg, follows previously existing approaches, very similar to the way the flu vaccine works. Initial tests on mice have proven successfully in producing copious antibodies against covid-19. The vaccine delivery system is both painless and highly scalable. So whether or not PittCoVacc is the "silver bullet" here, it's existence shows that the energies and innovation of our research companies is yielding good options - a process that should only accelerate from here. And now that we have more data, it really does appear that the hydroxycholorquine/azithromycin cocktail combo reduces the severity and duration of covid-19 infection - provided it's delivered early on enough. These encouraging developments, plus an exploding set of citizen-entreprenuers creating their own DIY solutions (especially with masks) give us the first real sense that we are beginning to make real progress against the coronavirus. We'll need to hold tight to that good news, as the next few weeks will be quite traumatizing with the expected huge increases in # of infected and deaths. But will well get through this. And it's heartening to see promising developments like PittCoVac and hydroxycholoquine begin to put points on the board for our side.
Christopher Martenson is a former American biochemical scientist. Currently he is a writer and trend forecaster interested in macro trends regarding the economy, energy composition and environment. He is the founder of PeakProsperity.com. As one of the early econobloggers who forecasted the housing market collapse and stock market correction years in advance, Chris rose to prominence with the launch of his seminal video seminar which later became a book called The Crash Course. Chris' latest book (co-authored with Adam Taggart) is called Prosper!: How to Prepare for the Future and Create a World Worth Inheriting.